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Abstract:  Problem  statement:  The  disruption  of  gut  barrier  function  plays  a  crucial  role  in  the 
pathogenesis of  not only  gastrointestinal diseases, but also the diseases of liver and  other organs. 
Mucosal protective factors that preserve the gut barrier integrity are beneficial in the prevention and 
treatment of such diseases. Probiotics is a group of helpful bacteria that protect the gastrointestinal 
mucosa  from  a  variety  of  insults.  Therefore,  understanding  the  mechanism  of  probiotic-mediated 
protection of gut barrier function is an important area of investigation. Approach: Several studies had 
addressed  the  role  of  probiotics  in  the  protection  of  gut  barrier  integrity.  In  a  recent  study,  we 
investigated the role of Lactobacillus rhamnosus GG and two soluble proteins, p40 and p75, in the 
protection  of  gut  barrier  function  in  Caco-2  cell  monolayer,  a  model  of  the  intestinal  epithelium. 
Results:  Studies  demonstrated  that  live  or  dead  Lactobacillus  rhamnosus  GG  prevents  oxidative 
stress-induced  disruption  of  tight  junctions  and  barrier  function  in  Caco-2  cell  monolayers.  The 
isolated soluble proteins of this probiotic, p40 and p75, also prevent hydrogen peroxide-induced tight 
junction  disruption.  This  protective  effect  of  probiotic  proteins  was  mediated  by  the  activation  of 
ERK1/2 and protein kinase C isoforms, PKCbI and PKCe. Conclusion: Lactobacillus rhamnosus GG 
prevent oxidative stress-induced disruption of intestinal epithelial tight junctions and barrier function, 
suggesting that preservation of epithelial barrier function is one of the mechanisms involved in the 
mucosal protective role of probiotics in the gut. 
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INTRODUCTION 
 
  Probiotics, the live microorganisms that inhabit the 
gastrointestinal tract, confer health benefits to the host, 
such  as  nutritional  assistance,  maturation  of  immune 
system,  protection  of  mucosal  barrier  function  and 
prevention  of  injurious  effects  caused  by  xenobiotics 
and pathogens
[1]. A flurry of basic and clinical studies 
on probiotics during the past decade lead FAO/WHO to 
define probotics as “live microorganisms which, when 
consumed in adequate amounts as part of food, confer a 
health benefit on the host”
[2]. Probiotics are considered 
to  offer  potential  therapeutic  applications  in  the 
prevention  and  treatment  of  different  diseases.  The 
current  clinical  applications  of  probiotics  include 
treatment  and/or  prevention  of  inflammatory  bowel 
diseases,  diarrhea,  irritable  bowel  syndrome,  gluten 
intolerance,  gastroenteritis  and  Helicobacter  pylori 
infection
[3].  A  significant  body  of  evidence  indicates 
that probiotics regulate intestinal epithelial homeostasis, 
such  as  promotion  of  cell  survival  and  barrier 
function
[4-6], improve intestinal microbial ecology and 
regulate immune function
[7].  
 
Lactobacillus rhamnosus: Probiotics in the gut include 
30 species of Bifidobacteria, 52 species of Lactobacillus 
and  others  such  as  Saccharomyces,  Streptococcus  and 
Enterococcus.  Lactobacillus  rhamnosus  GG  (LGG), 
originally isolated from the healthy human intestine
[8], 
is one of the best-studied probiotic bacteria in clinical 
trials  for  treating  and/or  preventing  several  intestinal 
disorders, including inflammatory bowel diseases and 
diarrhea
[7]. Recent mechanistic studies using LGG as a 
model of probiotic bacterium find that LGG prevents 
cytokine-induced  apoptosis  in  the  intestinal  epithelial 
cells through activation of Akt and prevention of p38-
MAPK  activation
[5].  More  importantly,  constituents 
recovered  from  LGG  culture  broth  supernatant 
stimulate  Akt  action  to  prevent  cytokine-induced 
apoptosis  in  intestinal  epithelial  cells
[5].  Furthermore, 
two LGG-produced soluble proteins, p75 and p40, have 
been  successfully  purified  and  cloned.  Both  p75  and Am. J. Infect. Dis., 5 (3): 188-192, 2009 
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p40 activate Akt and regulate intestinal epithelial cell 
anti-apoptotic responses
[6]. In the gastrointestinal tract 
LGG  promote  good  digestion,  boost  immune  system, 
increase  resistance  to  infection  and  inhibit  growth  of 
pathogenic bacteria. One of the important mechanisms 
by which LGG exerts its beneficial effect in gut appears 
to be the protection of mucosal barrier function.  
 
Tight  junctions  and  gut  barrier  function:  Gut 
mucosal  barrier  function  prevents  the  diffusion  of 
potential  injurious  factors  from  the  gastrointestinal 
lumen into the tissue and eventually into the systemic 
circulation
[9].  Disruption  of  barrier  function  and 
elevated permeability to luminal toxins, allergens and 
pathogens play a crucial role in the pathogenesis of a 
number  of  gastrointestinal  diseases  such  as 
inflammatory  bowel  disease,  celiac  disease  and 
alcoholic  liver  disease.  A  major  component  of  the 
mucosa barrier function is the specialized intercellular 
junctional  complex  called  tight  junctions,  a 
circumferential  ring  located  at  the  apical  end  of  the 
lateral membrane of the epithelial cells. Tight junctions 
are formed by the organization of a number of specific 
proteins such as occludin, zonula occludens (ZO-1, ZO-
2  and  ZO-3),  claudins  and  junctional  adhesion 
molecule
[9].  The  assembly  and  disassembly  of  tight 
junctions  are  regulated  by  numerous  intracellular 
signaling molecules
[10].  
  Proinflammatory  factors  such  as  reactive  oxygen 
species
[11-15],  cytokines
[16,17]  and  toxins
[18]  disrupt  the 
tight junction and compromise the barrier function of 
the  intestinal  epithelium.  Previous  studies  have 
demonstrated  that  hydrogen  peroxide  disrupts  tight 
junctions in the Caco-2 cell monolayer by a mechanism 
involving phosphotidylinositol 3-kinase
[15] and c-Src
[11]. 
Hydrogen  peroxide  induces  a  redistribution  of  tight 
junction and adherens junction proteins, occludin, ZO-
1,  E-cadherin  and  b-catenin,  from  the  intercellular 
junctions  into  the  intracellular  compartments.  The 
factors  that  prevent  the  inflammation-mediated 
disruption of the tight junction and barrier function may 
provide potential therapeutic benefit in the treatment of 
many gastrointestinal diseases. 
 
Approach and results: LGG has been shown to protect 
the  intestinal  mucosal  integrity  by  preventing  the 
cytokine-induced  apoptosis  of  epithelial  cells
[5].  The 
probiotic,  Escherichia  coli  Nissle  1917,  mediates  up 
regulation of tight junction protein, ZO-1 and prevents 
gut  barrier  disruption  induced  by  sodium  dextran 
sulfate-induced  colitis
[19].  In  a  recent  study  we 
evaluated the effect of LGG and proteins secreted by 
LGG  (p75  and  p40)  on  hydrogen  peroxide-induced 
disruption of tight junctions in Caco-2 cell monolayers, 
a  cell  culture  model  of  the  intestinal  epithelium
[20]. 
Pretreatment  of  cell  monolayers  with  p40  or  p75 
attenuated the hydrogen peroxide-induced decrease in 
TER and increase in inulin permeability in a time and 
dose-dependent  manner.  Probiotic  proteins,  p40  and 
p75  prevented  hydrogen  peroxide-induced 
redistribution  of  occludin,  ZO-1,  E-cadherin  and  b-
catenin  from  the  intercellular  junctions  and  their 
dissociation  from  the  detergent-insoluble  fractions. 
Both  p40  and  p75  induced  a  rapid  increase  in  the 
membrane  translocation  of  PKCbI  and  PKCe.  The 
attenuation  of  hydrogen  peroxide-induced  inulin 
permeability  and  redistribution  of  tight  junction 
proteins by p40 and p75 was abrogated by Ro-32-0432, 
a  PKC  inhibitor.  LGG  proteins,  p40  and  p75  also 
rapidly increased the levels of phospho-ERK1/2 in the 
detergent-insoluble  fractions.  U0126  (a  MAP  kinase 
inhibitor)  attenuated  the  p40  and  p75-mediated 
reduction of hydrogen peroxide-induced tight junction 
disruption and inulin permeability.  
  The  attenuation  of  hydrogen  peroxide-induced 
increase  in  inulin  permeability  in  Caco-2  cell 
monolayers by live or dead LGG suggested that certain 
component  of  LGG  is  responsible  for  this  protective 
response. Protection of tight junctions from hydrogen 
peroxide by LGG supernatant and the purified proteins, 
p40  and  p75,  indicated  that  the  proteins  secreted  by 
LGG  are  involved  in  the  amelioration  of  oxidative 
stress-induced increase in paracellular permeability. A 
previous study demonstrated that the probiotics protect 
the  intestinal  epithelial  cells  from  TNFa-induced 
apoptosis
[5].  Although  ZO-1  and  occludin  levels  in 
detergent-insoluble fractions were dramatically reduced 
by  H2O2  treatment,  confocal  microscopy  showed  that 
redistribution of occludin from the junctions was much 
more pronounced compared to the redistribution of ZO-
1. This may be explained by proposing a possibility that 
H2O2 had only minimal effect on the interaction between 
ZO-1 and claudins and therefore a significant portion of 
ZO-1  remains  to  be  localized  at  the  intercellular 
junctions. The adherens junction  lies beneath  the tight 
junction and is formed by the organization of E-cadherin 
and  b-catenin.  Evidence  suggests  that  the  adherens 
junction  indirectly  regulates  the  integrity  of  tight 
junction.  The  probiotic  proteins  (p40  and  p75)  also 
prevent hydrogen peroxide-induced redistribution of E-Am. J. Infect. Dis., 5 (3): 188-192, 2009 
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cadherin  and  b-catenin.  Therefore,  probiotics  may 
stabilize both tight junction and adherens junction and 
preserve the integrity of barrier function.  
  Probiotic secretory proteins, LGG supernatant, p40 
and p75, did not change the level of hydrogen peroxide, 
indicating that the effect of probiotic was not mediated 
by an antioxidant effect. This was further supported by 
the  observation  that  LGG  supernatant  effectively 
prevented  hydrogen  peroxide-induced  disruption  of 
barrier  function  when  the  cells  were  pretreated  with 
LGG  supernatant  and  removed  before  the 
administration of hydrogen peroxide. P40 and p75 were 
effective  in  preventing  hydrogen  peroxide-induced 
disruption  of  tight  junction  even  when  they  were 
administered  only  to  the  apical  surface  or  the  basal 
surface.  This  indicates  that  the  necessary  membrane 
receptors  required  for  their  protective  effects  are 
present  in  both  the  apical  and  the  basolateral 
membranes  of  Caco-2  cell  monolayers.  Probiotic 
protein, p75, also prevented hydrogen peroxide-induced 
disruption  of  barrier  function  in  T84  and  HT29  cell 
monolayers, indicating that this effect is not confined to 
one cell line.  
  Both p40 and p75 are novel bacterial proteins, which 
induce  intestinal  epithelial  cell  signal  transduction  and 
anti-apoptotic responses
[5]. The deduced full-length p40 
sequence is 79% identical to the sequence of a 396 amino 
acid protein of unknown function in Lactobacillus casei 
334  (NCBI  GeneBank  COG3883)  and  the  partial 
sequence of p75, which is most closely related to a 493-
amino-acid cell wall-associated hydrolase of L. casei 334 
(NCBI GeneBank COG0791). The predicted molecular 
mass of the full-length cell wall-associated hydrolase of 
Lactobacillus casei 334 (49 kDa) differs substantially 
from the molecular mass of the LGG p75 protein. The 
p40 gene sequence and the partial p75 gene sequence 
do  not  show  significant  similarity  and  the 
experimentally  determined  N-terminal  amino  acid 
sequences of these two proteins are not related. Thus, 
based  on  the  available  sequence  data,  there  is  no 
evidence to suggest that p40 is a degradation product of 
p75.  However,  it  is  possible  that  there  could  be 
sequence  similarity  between  p40  and  the 
uncharacterized  C-terminal  portion  of  p75.  The 
mechanisms of p40 and p75 regulating cell  signaling 
are  an  area  of  active  investigation  including 
identification  of  potential  interacting  proteins  and 
potential receptor(s), however no candidates have been 
clearly identified so far. 
  Both p40 and p75 effectively prevented hydrogen 
peroxide-induced  loss  of  tight  junction  and  adherens 
junction proteins from the detergent-insoluble fractions. 
Previous  studies  showed  that  the  tight  junction  and 
adherens junction proteins, occludin, ZO-1, E-cadherin 
and  b-catenin  are  associated  with  the  F-actin-rich 
Triton-insoluble  fractions  in  an  intact  epithelium  and 
these  fractions  of  the  tight  junction  and  adherens 
junction  proteins  correlate  well  with  the  integrity  of 
tight  junction
[13].  Hydrogen  peroxide  caused  a 
dissociation  of  these  tight  junction  and  adherens 
junction proteins from the detergent-insoluble fractions, 
suggesting  that  the  dissociation  of  tight  junction  and 
adherens junction proteins from the actin cytoskeleton 
is one of the mechanisms involved in this tight junction 
disruption.  Probiotic  proteins  somehow  prevent 
hydrogen peroxide-induced loss of interaction between 
the  actin  cytoskeleton  and  the  tight  junction  and 
adherens  junction  proteins.  Therefore,  the  protective 
effects  of  P40  and  P75  are likely  to  be  mediated  by 
specific  cellular  mechanisms.  It  was  shown  that  p40 
and p75 activate Akt in the intestinal epithelial cells
[5]. 
However, phopho-Akt was undetectable in p40 or p75-
treated Caco-2 cells. Therefore, probiotic-mediated Akt 
activation may play a role in cell survival effect, but is 
not  involved  in  the  protection  of  tight  junction  from 
hydrogen peroxide (data not shown). 
  Attenuation  of  the  P40  and  P75-mediated 
protection of barrier function and tight junction from 
hydrogen  peroxide  by  Ro-32-0432  (a  PKC-selective 
inhibitor) indicates that PKC activity is involved in the 
tight junction protection by probiotic secretory proteins. 
Ro-32-0432 is known to selectively inhibit the activities 
of PKCa, PKCe and PKCbI. Both p40 and p75 rapidly 
increase  the  membrane  translocation  of  PKCe  and 
PKCbI; membrane localization of PKCa was unaltered. 
This indicates that p40 and p75 induce the activation of 
PKCe  and  PKCbI  and  this  activation  of  the  PKC 
isoforms  may  be  required  for  the  protection  of  tight 
junction  from hydrogen peroxide. Maximal activation 
of  PKCbI  was  achieved  by  2  min,  while  PKCe 
translocation was detectable only at 15 min after p75 
administration.  This  suggests  that  PKCbI  activation 
may be one of the initial events in the mechanism of 
probiotic-mediated  protection  of  tight  junction  and 
adherens junction. PKCe may play a role in the down 
stream events of the signaling pathway involved in this 
process. 
  Studies  also  showed  that  MAP  kinase  activity  is 
involved in the p40 and p75-mediated prevention of the 
hydrogen peroxide-induced disruption of tight junction Am. J. Infect. Dis., 5 (3): 188-192, 2009 
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and  increase  in  paracellular  permeability.  U0126  (a 
MEK selective inhibitor) attenuates the protective effect 
of p40 and p75 on tight junction, indicating that these 
probiotic proteins activate ERK1/2 via MEK activity. 
This is confirmed by the demonstration that both p40 
and p75 rapidly increase the level of p-ERK in Caco-2 
cells.  A  recent  study  demonstrated  that  activation  of 
ERK  plays  a  crucial  role  in  the  EGF-mediated 
prevention of hydrogen peroxide-induced disruption of 
tight  junction  and  the  increase  in  paracellular 
permeability
[22]. Phospho-ERK directly interacted with 
occludin  and  prevented  hydrogen  peroxide-induced 
dephosphorylation  of  occludin  on  Thr  residues.  A 
similar  mechanism  may  play  a  role  in  the  probiotic-
mediated protection of the tight junction from hydrogen 
peroxide-induced insult.  
  PKC inhibitors failed to prevent probiotic-induced 
activation  of  ERK1/2  and  similarly,  MEK  inhibitor 
failed  to  prevent  probiotic-induced  membrane 
translocation of PKCe or PKCbI. These data suggested 
that  probiotic-induced  activation  of  MAP  kinase  and 
PKC  signaling  pathways  are  independent  of  one 
another.  Therefore,  it  is  likely  that  probiotic  proteins 
activate multiple signaling pathways and coordination 
these signaling pathways is required for the probiotic-
mediated  protection  of  intestinal  epithelial  tight 
junctions. The precise mechanism involved in PKC and 
MAP  kinase  activation  in  tight  junction  regulation  is 
not  known.  A  recent  study  suggested  that  PKC 
activation is involved in stabilization of perijunctional 
actomyosin  ring
[21].  MAP  kinase  activation  may 
regulate the Thr-phosphorylation of Occludin. 
 
CONCLUSION 
 
  The evidence is convincing that probiotics protect 
the  gastrointestinal  mucosa  from  a  variety  of  insults 
including  infection  by  harmful  bacteria.  Several 
mechanisms appear to be associated with this mucosal 
protective role of probiotics. One such mechanism may 
involve preservation of the integrity of epithelial tight 
junctions and therefore the gut barrier function. Recent 
studies  demonstrate  that  soluble  proteins  of 
Lactobacillus rhamnosus GG are effective in protecting 
the  epithelia  tight  junctions  from  oxidative  stress  by 
activating  intracellular  signaling  mechanisms. 
Therefore, probiotics and the soluble proteins may offer 
potential  therapeutic  benefits  in  the  prevention  and 
treatment of gastrointestinal diseases and possibly other 
systemic pathophysiological conditions.  
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